Saul P. Corticosteroid therapy for asthma raises risk of osteoporosis and fragility fractures. Practitioner October 2020;264(1841):7
Corticosteroid therapy for asthma raises risk of osteoporosis and fragility fractures
27 Oct 2020
Use of oral or inhaled corticosteroids appears to be an independent risk factor for osteoporosis and fragility fractures in patients with asthma, a UK population-based study has found.
This article can only be accessed if you are a registered user of thepractitioner.co.uk or a subscriber to The Practitioner.

= Paid-up subscribers